Stanford University
Showing 4,661-4,680 of 7,899 Results
-
Elizabeth Mellins
Member, Bio-X
Current Research and Scholarly InterestsMolecular mechanisms and intracellular pathways of MHC class II antigen processing and presentation, with a focus on B cells; mechanisms underlying HLA allele association with disease; disease mechanisms in systemic juvenile idiopathic arthritis, including an HLA-linked complication; monocytes as drivers or suppressors of auto-inflammation in systemic juvenile idiopathic arthritis and pediatric acute neuropsychiatric syndrome.
-
Michelle Mello
Professor of Law and of Health Policy
BioMichelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine. She conducts empirical research into issues at the intersection of law, ethics, and health policy. She is the author of more than 250 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, artificial intelligence, health information privacy, and other topics.
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40. From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
Dr. Mello teaches courses in torts and public health law. She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. -
Nicholas Melosh
Professor of Materials Science and Engineering
BioThe Melosh group explores how to apply new methods from the semiconductor and self-assembly fields to important problems in biology, materials, and energy. We think about how to rationally design engineered interfaces to enhance communication with biological cells and tissues, or to improve energy conversion and materials synthesis. In particular, we are interested in seamlessly integrating inorganic structures together with biology for improved cell transfection and therapies, and designing new materials, often using diamondoid molecules as building blocks.
My group is very interested in how to design new inorganic structures that will seamless integrate with biological systems to address problems that are not feasible by other means. This involves both fundamental work such as to deeply understand how lipid membranes interact with inorganic surfaces, electrokinetic phenomena in biologically relevant solutions, and applying this knowledge into new device designs. Examples of this include “nanostraw” drug delivery platforms for direct delivery or extraction of material through the cell wall using a biomimetic gap-junction made using nanoscale semiconductor processing techniques. We also engineer materials and structures for neural interfaces and electronics pertinent to highly parallel data acquisition and recording. For instance, we have created inorganic electrodes that mimic the hydrophobic banding of natural transmembrane proteins, allowing them to ‘fuse’ into the cell wall, providing a tight electrical junction for solid-state patch clamping. In addition to significant efforts at engineering surfaces at the molecular level, we also work on ‘bridge’ projects that span between engineering and biological/clinical needs. My long history with nano- and microfabrication techniques and their interactions with biological constructs provide the skills necessary to fabricate and analyze new bio-electronic systems.
Research Interests:
Bio-inorganic Interface
Molecular materials at interfaces
Self-Assembly and Nucleation and Growth -
Jamie Meltzer
Professor of Art and Art History
BioProfessor Jamie Meltzer teaches in the M.F.A. Program in Documentary Film. His feature documentary films have been broadcast nationally on PBS and have screened at numerous film festivals worldwide. Shifted Landscapes, a documentary feature in production, presents a mosaic of stories depicting the environmental, cultural, and psychological landscapes of California amidst the ongoing climate crisis. His short documentary, not even for a moment do things stand still, premiered at SXSW in March 2022, winning a Special Jury Mention in Visual Reflection. The film provides an observational glimpse into a COVID-19 art installation, dropping into intimate moments of people honoring their loved ones, and interrogating the role of mourning and closure during an unfolding tragedy. It was published as a New York Times Op-Doc in April 2022. Huntsville Station, a short documentary film directed with Chris Filippone, was featured as a New York Times Op-Docs and premiered at Berlinale and SXSW in 2020. The film observes the scene at a bus station - where dozens of inmates just released on parole take in their first moments of freedom before taking the bus home. True Conviction (broadcast on Independent Lens in May 2018), a co-production of ITVS and the recipient of a Sundance Institute grant and a MacArthur grant, premiered at the Tribeca Film Festival where it received a Special Jury Mention in the Best Documentary Feature category. Informant (2012), about a revolutionary activist turned FBI informant, was released in theaters in the US and Canada in Fall 2013 by Music Box Films and KinoSmith. Previous films include: Off the Charts: The Song-Poem Story (Independent Lens, 2003), about the shadowy world of song-poems, Welcome to Nollywood (PBS Broadcast, 2007), an investigation into the wildly successful Nigerian movie industry, and La Caminata (2009), a short film about a small town in Mexico that runs a simulated border crossing as a tourist attraction.
-
Fernando S. Mendoza
Associate Dean of Minority Advising and Programs and Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsI have two research interests: childhood health disparities and workforce diversity. My research on childhood health disparities centers on Latino and immigrant children with a focus on early childhood health and development. My work in workforce diversity examines the pipeline for diversity in academic pediatrics, with special attention on the pipeline for underrepresent minorities.
-
Teresa Meng
Reid Weaver Dennis Professor in Electrical Engineering and Professor of Computer Science, Emerita
BioTeresa H. Meng is the Reid Weaver Dennis Professor of Electrical Engineering, Emerita, at Stanford University. Her research activities in the first 10 years focused on low-power circuit and system design, video signal processing, and wireless communications. In 1998, Prof. Meng took leave from Stanford and founded Atheros Communications, Inc., which developed semiconductor system solutions for wireless network communications products. After returning to Stanford in 2000 to continue her teaching and research, Prof. Meng turned her research interest to applying signal processing and IC design to bio-medical engineering. She collaborated with Prof. Krishna Shenoy on neural signal processing and neural prosthetic systems. She also directed a research group exploring wireless power transfer and implantable bio-medical devices. Prof. Meng retired from Stanford in 2013.
-
Joshua Menke
Clinical Associate Professor, Pathology
BioDr. Joshua Menke completed his hematopathology fellowship at Stanford and a cytopathology fellowship at the University of California, San Francisco (UCSF). His clinical and research interests lie at the intersection of hematopathology, cytopathology, and advanced single-cell and cell-free diagnostic techniques. As the Associate Section Director of Clinical Flow Cytometry at Stanford, Dr. Menke is developing and validating new minimal residual disease assays for detecting low levels of myeloid and lymphoid neoplasms in the post-treatment setting, as well as multiple other 12-color flow assays with the latest markers for routine phenotyping.
Dr. Menke is the recipient of the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and the Laurence J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboratory. Dr. Menke is a founding member of the Cytology-Hematopathology Interinstitutional Collaboration (CHIC), which aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions. He currently chairs this group, leading large clinical research studies. -
Jisha Menon
Robert G. Freeman Professor of International Studies, Director of Stanford Global Studies and Professor, by courtesy, of Comparative Literature
BioJisha Menon is the Robert G. Freeman Professor of International Studies. She serves as the Sakurako and William Fisher Family Director of the Stanford Global Studies Division. She is Professor of Theater and Performance Studies, and (by courtesy) of Comparative Literature. Her research interests lie at the intersection of critical theory and performance studies; law and humanities; affect theory, cities, and capitalism; cosmopolitanism and nationalism. Her current research project, Law, Affect, and the Performance of Personhood (under contract, Cambridge UP) explores how legal practices entrench a particular liberal topology of personhood, and how this conception departs from other societies where persons are conceived in more plural and discontinuous ways. The book argues that attending to the fictive constitution of the person within the law allows us to highlight the artifice, indeed, the aesthetics that are central to jurisprudence. Her four books explore arts and aesthetics in relation to neoliberal capitalism, postcolonial nationalism, secularism, and geopolitical conflict. Her latest book, Brutal Beauty: Aesthetics and Aspiration in Urban India (Northwestern UP, 2021) considers the city and the self as aesthetic projects that are renovated in the wake of neoliberal economic reforms in India. The study explores how discourses of beauty are mobilized toward anti-democratic ends. Sketching out scenes of urban aspiration and its dark underbelly, the book delineates the creative and destructive potential of India’s lurch into contemporary capitalism. Her first book, The Performance of Nationalism: India, Pakistan and the Memory of Partition (Cambridge UP, 2013), examines the affective and performative dimensions of nation-making. The book recuperates the idea of "mimesis" to think about political history and the crisis of its aesthetic representation, while examining the mimetic relationality that undergirds the encounter between India and Pakistan. She is also co-editor of two volumes: Violence Performed: Local Roots and Global Routes of Conflict (with Patrick Anderson) (Palgrave-Macmillan Press, 2009) and Performing the Secular: Religion, Representation, and Politics (with Milija Gluhovic) (Palgrave Macmillan, 2017.) In addition to her scholarly work, she is a director, actor, and playwright. Her co-authored play, City of Gardens (with Abhishek Majumdar), was published by Dawran Press in 2026. Previously, she served as Assistant Professor of English at the University of British Columbia in Vancouver, Canada.
-
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Antonio Meola, MD, PhD
BioAntonio Meola M.D. Ph.D graduated Summa cum Laude and Research Honors at the University of Pisa, Italy, in 2008, and completed his residency training in Neurosurgery at the same Institution in July 2015. Dr Meola attended a Ph.D. program at the University of Florence, Italy, where he discussed a doctoral thesis entitled "A New Head-Mounted Display-based Augmented Reality System in Neurosurgical Oncology: a study on phantom".
Since 2/2014 to 1/2015 Dr Meola completed a Research Fellowship in Neurosurgical anatomy at the University of Pittsburgh Medical Center (UPMC), under the Direction of Dr. Juan C. Fernandez-Miranda. The main focus of his research was the surgical neuroanatomy of the white matter tracts of the human brain.
Since 7/2015 to 6/2016 Dr Meola served as Clinical Fellow in Image-Guided Neurosurgery at the Brigham and Women's Hospital, Harvard Medical School, in Boston, MA (Director: Dr. Alexandra J. Golby M.D.). During the fellowship, he focused on the clinical application and integration of advanced imaging techniques, including intraoperative-MRI, intraoperative US, functional MRI, tractography.
Since 7/2016 to 6/2017 Dr Meola completed a Neurosurgical Oncology Fellowship at the Cleveland Clinic in Cleveland, OH, devoting his efforts to minimally-invasive neurosurgical techniques, such as Laser interstitial Thermal Therapy (LITT) and stereotactic radiosurgery (Gamma Knife), as well as to awake neurosurgery.
Starting 7/2017, Dr Meola joined the Department of Neurosurgery at Stanford. Dr. Meola mainly focuses on conventional and innovative treatments for brain and skull base tumors, including both surgery and stereotactic radiosurgery (CyberKnife). -
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq. -
Dr Tom Meredith, MD, PhD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr Tom Meredith, born and raised in Melbourne, Australia, is an academic interventional cardiologist and a clinical assistant professor at Stanford. He completed his medical and cardiology specialty training through the University of New South Wales and St Vincent's Hospital in Sydney, Australia. After obtaining Fellowship at the Royal Australian College of Physicians, he completed three years of coronary and structural interventional training across St Vincent’s Hospital and Stanford. Alongside his clinical training, he completed a master's degree in clinical trials research as well as a PhD through the Victor Chang Cardiac Research Institute, supported by competitive scholarship funding from the CSANZ and the Australian National Heart Foundation. During his PhD he developed and patented a novel algorithm to predict aortic stenosis severity from single-view echocardiography and his thesis was ultimately nominated for the Dean's Award. His research interests include cardiac remodelling in valvular heart disease and the application of supervised machine-learning methods to predict post-procedural outcomes. Outside medicine, Tom is a dedicated father and avid triathlete who has competed in multiple Ironman 70.3 World Championships.
